{
  "symbol": "CBLL",
  "company_name": "Ceribell Inc",
  "ir_website": "https://ceribell.gcs-web.com/",
  "structured_data": [
    {
      "section_name": "Error Details",
      "links": [
        {
          "title": "Error Code: ERR_HTTP2_PROTOCOL_ERROR",
          "url": "https://ceribell.gcs-web.com",
          "content": "[Skip to content](#lfg-main-content)\n\n![](/sites/g/files/knoqqb95036/themes/site/client_site/dist/images/Home-banner-SAFER-1.png)\n\n# Investor Relations\n\n## Corporate Overview\n\nCeribell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence (“AI”)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA 510(k) cleared for indicating suspected seizure activity and currently utilized in intensive care units and emergency rooms across the U.S. \n\n![Image Stock Chart](https://api.nasdaqomx.wallst.com/api/chart?display=mountain&symbol=CBLL.O-CBLL&scale=linear&duration=1dy&frequency=15min&gridLine=h&bgColor=f5f5f4&lineColor=0077c8&fillcolor=0077c8|ffffff&width=100%&height=200&volume=0&bdr=3&fillOpacity=90&fontColor-C1=333333&gridLineColor=6c7577&fontStyle=1&bdrColor=41B6E6)\n\nMinimum 15 minutes delayed. Source: LSEG\n\n## News Releases\n\n[All News Releases](https://ceribell.gcs-web.com/news-events/news-releases)\n\nNovember 19, 2024 \n\n[Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing](/news-releases/news-release-details/ceribell-appoints-kristie-rodenbush-chief-people-officer-and)\n\nNovember 12, 2024 \n\n[Ceribell Reports Third Quarter 2024 Financial Results](/news-releases/news-release-details/ceribell-reports-third-quarter-2024-financial-results)\n\nNovember 11, 2024 \n\n[Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs](/news-releases/news-release-details/ceribell-receives-authority-operate-us-department-veterans)\n\n[Show all](#)\n\n## Latest Earnings\n\n### Q3 2024 Results\n\n[All Quarterly Results](https://ceribell.gcs-web.com/financial-information/quarterly-results)\n\n  * [downloadCeribell Reports Third Quarter 2024 Financial Results](/news-releases/news-release-details/ceribell-reports-third-quarter-2024-financial-results)\n\n  * [mic Ceribell Q3 2024 Earnings Call](/events/event-details/ceribell-q3-2024-earnings-call)\n\n  * [downloadForm 10-Q](/sec-filings/sec-filing/10-q/0000950170-24-125409)\n\n\n\n\n## Events\n\nNovember 12, 2024 4:30 PM EST\n\n[Ceribell Q3 2024 Earnings Call](/events/event-details/ceribell-q3-2024-earnings-call)\n\nNovember 21, 2024 10:00 AM PST\n\n[Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum](/events/event-details/canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum)\n\n## Presentations\n\n[All Presentations](/news-events/presentations)\n\n[Ceribell Investor Presentation - November 2024](/static-files/18b735aa-d217-4df6-ac9e-3451a2768aa7)\n"
        }
      ]
    }
  ]
}